Press Releases about Hutchmed China Ltd ADR
HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
September 24, 2024
Via GlobeNewswire
HUTCHMED to Host Expert Call to discuss Immune Thrombocytopenia
August 21, 2024
Via GlobeNewswire
HUTCHMED to Announce 2024 Half-Year Financial Results
June 26, 2024
Via GlobeNewswire
Via GlobeNewswire
HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
February 28, 2024
Via GlobeNewswire
HUTCHMED to Announce 2023 Final Results
February 01, 2024
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|